Agreed.
Cohort three efficacy results........... No such thing. It will not be efficacious in the sense some here are hoping. There will be a cohort four and a cohort five to test the real action of TT-034. All I am hoping for is good transduction and shRNA delivery, followed by a very mild viral response, even if short lived. That will be my efficacy. It is a concept trial.
Updated listing price, page-28
-
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)